{"retracted":false,"update":{"timestamp":1473638400000,"doi":"10.1186/s40814-016-0095-6","type":"correction"},"doi":"10.1186/s40814-016-0046-2","journal":"Pilot and Feasibility Studies","publisher":"Springer Nature","title":"Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection"}
